Arcadia Biosciences, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2014 | $8.9M | $-84.8M | $16.6M |
| FY2015 | $24.9M | $40.2M | $24.0M |
| FY2016 | $25.1M | $22.2M | $2.0M |
| FY2017 | $0 | $8.0M | $9.1M |
| FY2018 | $0 | $12.8M | $12.0M |
| FY2019 | $107.0K | $7.7M | $8.4M |
| FY2020 | $3.2M | $27.7M | $14.0M |
| FY2021 | $0 | $31.1M | $28.7M |
| FY2022 | — | $21.0M | $20.6M |
| FY2023 | — | $12.8M | $6.5M |